Serotonin induces peripheral antinociception via the opioidergic system

Area of Science:

• Neuroscience
• Pharmacology
• Pain Research

Background:

• Serotonin (5-HT) release in the spinal cord dorsal horn is known to contribute to opioid analgesia.
• Previous research has established a link between serotonin and opioid-mediated pain relief.
• The role of serotonin in peripheral pain modulation remains less understood.

Purpose of the Study:

• To investigate the involvement of the opioidergic system in serotonin-induced peripheral antinociception.
• To examine how serotonin affects pain sensitivity at the peripheral level.
• To elucidate the potential mechanisms underlying serotonin's analgesic effects.

Main Methods:

• Utilized the paw pressure test in male Swiss mice to assess pain sensitivity.
• Induced hyperalgesia via intraplantar injection of prostaglandin E2 (PGE2).
• Administered serotonin locally to the paw to evaluate its antinociceptive effects.

Main Results:

• Selective antagonists for mu, delta, and kappa opioid receptors blocked serotonin's antinociceptive effect.
• Bestatin, an enkephalinase inhibitor, enhanced serotonin-induced antinociception.
• These findings indicate a crucial role for opioid receptors and endogenous opioid peptides.

Conclusions:

• Serotonin likely induces peripheral antinociception by stimulating the release of endogenous opioid peptides.
• Potential sources of these opioid peptides include immune cells or keratinocytes in the periphery.
• This study highlights a novel peripheral mechanism for pain modulation involving serotonin and the opioidergic system.